Fonar Logo
diagnostic imaging management services

* FONAR is not responsible for the accuracy of information on these servers. This link is provided for your convenience only.

 

Fonar Financials Filed with the SEC

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

 

SEC Accession No. 0001731122-24-001763

Filing Date
2024-11-12
Accepted
2024-11-12 13:44:35
Documents
64
Period of Report
2024-09-30
 
Interactive Data
Document Format Files
Seq Description Document Type
1 FONAR 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2024 fonar_10_q.htm iXBRL 10-Q
2 SECTION 302 CERTIFICATION fonar_exhibit-31.htm EX-31
3 SECTION 906 CERTIFICATION fonar_exhibit-32.htm EX-32
4 GRAPHIC fonar_logo.jpg GRAPHIC
  Complete submission text file 0001731122-24-001763.txt  
Data Files
Seq Description Document Type
5 XBRL SCHEMA FILE fonr-20240930.xsd EX-101.SCH
6 XBRL CALCULATION fonr-20240930_cal.xml EX-101.CAL
7 XBRL DEFINITION FILE fonr-20240930_def.xml EX-101.DEF
8 XBRL LABEL FILE fonr-20240930_lab.xml EX-101.LAB
9 XBRL PRESENTATION FILE fonr-20240930_pre.xml EX-101.PRE
54 EXTRACTED XBRL INSTANCE DOCUMENT fonar_10-q_htm.xml XML
       

FONAR CORPORATION (Filer) CIK: 0000355019

IRS No.: 112464137 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q| Act: 34 | File No.: 000-10248 | Film No.: 241446663
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences

Business Address

110 Marcus Drive
Melville, NY 11740
631-694-2929
Mailing Address

110 Marcus Drive
Melville, NY 11740